Compass Pathways is trading 4.36% down at $14.14, with broader risk-off trading, higher yields and weaker major indexes appearing to be the primary explanation.
- No clearly reported negative company-specific catalyst was identified for September 23, 2026.
- The company is scheduled to participate in a TD Cowen neuropsychiatry summit fireside chat at 1:00 p.m. ET; available coverage does not indicate adverse news from the event.